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In this study, we employed l-ascorbic acid (AA), a well-known radical scavenger, as an antioxidant. By trapping radicals, AA prevents cell membrane oxidation and injury caused by ROS. Moreover, treatment with AA has been shown to reduce intracellular lipid peroxidation induced by talc nanoparticles in A549 cells 22) , and Ahmad et al. 23) reported that AA prevented ROS generation and activation of apoptosis signaling caused by silica nanoparticles. Additionally, AA potentially prevents not only oxidative stress but also inflammation. Tebbe et al. 24) reported that AA decreased secretion of the pro-inflammatory cytokines, IL-1α and IL-6, caused by UVA irradiation of human keratinocytes.
The aim of the present study was to use AA to prevent the acute pulmonary symptoms caused by ZnO NPs. Because ZnO NPs are known to induce oxidative stress and inflammation in the lung, we monitored biomarkers of oxidative stress and pro-inflammation responses.
Materials and Methods

ZnO NPs and chemicals
ZnO NPs (product name FZO-50) were purchased from Ishihara Sangyo Kaisha, Ltd. (Osaka, Japan). According to the manufacturer's material data sheets, the primary particle size was 21 nm, the purity was 97.4%, and the specific surface area was 49.6 m 2 / g. Ascorbic acid was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
Preparation of ZnO NP dispersion for intratracheal instillation
The ZnO NP dispersion for intratracheal instillation in this study was the same as that we previously reported 1) . To prepare the dispersion, 0.5 g of ZnO NP powder was mixed into 50 ml of endotoxin-free distilled water containing 5% (v/v) fetal bovine serum (FBS; CELLect GOLD; MP Biomedicals Inc., Solon, OH, USA). The particles were dispersed by ultrasonication for 3 hours in an ultrasonic bath (Branson 5510J-MT, 135 W, 42 kHz), with the temperature maintained below 30°C. Secondary particle size was adjusted by centrifugation at 16,000 × g for 5 minutes at room temperature. Thirty to 40 ml of the supernatant was collected, and the ZnO concentration was determined by UV absorbance at 380−700 nm. There was no endotoxin activity in the dispersion, as determined by the Limulus Amebocyte Lysate Assay (Pyrotell; Associates of Cape Cod, Inc., East Falmouth, MA, USA). The size distribution of the ZnO particles in the dispersion was measured by dynamic light scattering (DLS) using a Zetasizer Nano (Malvern Instruments Limited, Malvern, United Kingdom). The soluble zinc concentration in the dispersion was detected by colorimetry using 2-(5-bromo-2-pyridylazo)-5-[N-n-propyl-N-(3-sulfopropyl) amino] phenol, disodium salt, and dihydrate (5-Br-PAPS) (Dojindo Laboratories, Kumamoto, Japan), in accordance with the procedure outlined by Makino et al. 25) The ZnO dispersions were centrifuged at 16,000 × g for 20 minutes, and the supernatant was carefully collected. After suitable dilution of the supernatant, 400 µ l of supernatant, 100 µ l of 5 mM APS, 100 µ l of 1 mM DTCS and 50 µ l of 1 mM 5-Br-PAPS were added to 2.0 ml of a buffer (6 g of NaOH dissolved in 500 ml of 0.5 M HEPES, pH 7.8). The above solution was mixed well and incubated for 10 minutes at room temperature. Its absorbance at 555 nm was measured using a DU 530-spectrophotometer (Beckman Coulter Inc., Miami, FL, USA). The soluble zinc concentration was estimated from the standard curve for the zinc standard solution (Wako Pure Chemical Industries).
Animals and intratracheal instillation
All animal experiments were approved by the Institutional Animal Care and Use Committee of the National Institute of Advanced Industrial Science and Technology (AIST). Eight-week-old male Wistar rats were obtained from CLEA Japan Inc. (Tokyo, Japan). Rats were fed a standard diet and allowed to accli-matize to their environment for 1 week before experimentation.
In our previous study, the induction of acute lung toxicity, which associated with oxidative stress and injury, was observed with a dose of 0.4 ml containing 0.2 mg ZnO NPs 1) . Therefore, the ZnO dispersion (dose of 0.2 mg/0.4 ml) was administered to rats in a single intratracheal instillation in this study. Control rats were given 0.4 ml of distilled water containing 5% FBS. After intratracheal instillation, the control and experimental groups were further subdivided into groups given water and groups receiving AA until autopsy. The AA groups were supplied with 1% AA water beginning immediately after ZnO NPs instillation. Each rat could drink water freely. There were at least four rats in each group (Table 1) .
At 24 hours or 1 week after exposure, rats were anesthetized by intraperitoneal injection of 50 mg/ml of 5-ethyl-5-(1-methylbutyl)-2,4,6-trioxohexahydropyrimidine (pentobarbital sodium salt; Sigma-Aldrich Corp., St. Louis, MO, USA). At autopsy, blood was taken from the abdominal aorta, and a lung was then perfused with saline. Bronchoalveolar lavage fluid (BALF) was recovered by administering 5 ml of saline into the right lung while clamping the left main bronchus. The injection and recovery of saline were repeated three times, and 15 ml of BALF was collected. It was then centrifuged at 1,500 rpm for 10 minutes to remove cell debris, and the supernatant was collected and used for measurement of markers. For real-time polymerase chain reaction (PCR), total RNA was prepared from the left lung tissue using the RNeasy Protect Mini Kit (Qiagen GmbH, Hilden, Germany).
Measurement of LDH in BALF
Lactate dehydrogenase (LDH) activity in BALF was measured using the Cytotoxicity Detection Kit PLUS (LDH) (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer's instructions. The amount of formazan salt formed was measured at 492 nm using a Multiskan Ascent plate reader (Thermo Labsystems, Helsinki, Finland). LDH activity was estimated using a standard curve obtained from known concentrations of LDH from the porcine heart (Serva Electrophoresis GmbH, Heidelberg, Germany).
Measurement of the HO-1 concentration in BALF
Heme oxygenase-1 (HO-1) concentrations in BALF were measured using an enzyme-linked immunosorbent assay (ELISA) with the Rat Heme Oxygenase-1 (HO-1) EIA Kit (Takara Bio Inc., Otsu, Japan) according to the manufacturer's instructions.
Measurement of the IL-6 concentration in BALF
Interleukin-6 (IL-6) concentrations in BALF were measured using the Quantikine (R) IL-6 ELISA Kit (R&D Systems Inc., Minneapolis, MN, USA) according to the manufacturer's instructions.
Real-time PCR
The gene expression levels of HO-1, cytokineinduced neutrophil chemoattractant (CINC)-1, CINC-2, CINC-3 and MT-1 were determined by real-time PCR. Total RNA was isolated from lung tissue using the RNeasy Protect mini kit (Qiagen GmbH). Realtime PCR was conducted using a StepOne Real-Time PCR System (Life Technologies Corp., Carlsbad, CA, USA). Gene expression levels were analyzed by the ∆∆Ct method. PCR amplification of lung tissue was analyzed using TaqMan ® Gene Expression Assays (Life Technologies Corp.), with the rat β -actin gene as an endogenous control. The gene expression assays for HO-1, CINC-1, CINC-2, CINC-3, and MT-1 were designated as Rn00561387_m1, Rn00578225_m1, Rn00593435_m1, Rn00586403_m1, and Rn00821759_g1, respectively.
Statistical analysis
Data represent means ± SE of at least three separate experiments. Statistical analyses were performed via analysis of variance (ANOVA) using Tukey's test for multiple comparisons. The calculation methods are described in each figure legend.
Results
Characterization of the ZnO NPs dispersion
We reported the characterization data for the primary particle in the ZnO NP and ZnO dispersion in our previous study 1) . The same dispersion was also used for this study. The primary particle size was approximately 20−50 nm based on TEM observation, and the average secondary particle size of the ZnO NPs in the ZnO water for intratracheal instillation was 101 nm based on the light intensity measured by DLS. The concentration of Zn 2+ released from the ZnO NPs in the dispersion was 70 µ g/ml.
AA treatment eliminates the rise in LDH activity caused by ZnO NPs
Results for each animal group (1−4) are shown in Table 1 . Lung injury was determined based on the LDH activity in BALF (Fig. 1) . One day after intratracheal instillation of ZnO NPs, there was a significant increase in LDH activity in group 3 compared with the non-treated group. In contrast, despite the instillation of ZnO NPs, the group supplied with AA did not show any increase in LDH activity in BALF. After 1 week, no significant changes were observed in LDH activities in any of the groups compared with the non-treated group.
Antioxidant effect of AA on oxidative stress caused by ZnO NPs
The concentration of HO-1, one of the major oxidative stress response enzymes, increased significantly in BALF 1 day after intratracheal instillation of ZnO NPs ( Fig. 2A) . This was partially suppressed by supplying AA. Similarly, HO-1 gene expression in lung tissue was greatly induced 1 day after ZnO NPs instillation (Fig. 2B) . In contrast, there was no induction of HO-1 gene expression in group 4. After 1 week, no significant differences were observed between the groups.
Effects of AA on lung inflammation following intratracheal instillation of ZnO NPs
The concentration of IL-6, a pro-inflammatory cytokine, was measured in BALF. One day after ZnO NP instillation, the IL-6 concentration increased (Fig. 3A) , but that in group 4 remained the same as that in the non-treated group. At this time point, we also observed the induction of CINC-1 and CINC-3 gene expression in group 3, but not in group 4, where it was suppressed (Fig. 3B  and 3D) . No large increases in CINC-2 expression were observed (Fig. 3C) . After 1 week, there were no significant differences in IL-6 and CINCs between the groups.
Effect of AA on MT-1 levels in response to ZnO NPs
MT-1 gene expression was induced 1 day after intratracheal instillation of ZnO NPs, and it was little suppressed by supplying AA. (Fig. 4) . After 1 week, no significant differences were observed between the groups.
Concentration of AA in plasma after instillation of ZnO NPs
The plasma AA concentrations were increased in groups 2 and 4 after 1 day, but remained elevated only in group 4 after 1 week (Fig. 5) .
Discussion
It is known that ZnO NPs induce acute pulmonary dysfunction that is associated with oxidative stress 1) . They are also severely cytotoxic to cultured cells 6−13) . It was recently reported that an important factor in metal oxide nanoparticle toxicity is metal ion release 2, 3) . ZnO NPs release Zn 2+ into culture media, inducing intracellular ROS. In addition, cellular studies revealed that intracellular Zn 2+ release and induction of oxidative stress are key factors in the biological effects of ZnO NPs 14−16) , eventually leading to cell death. In vivo and in vitro studies have also shown that intratracheal instillation of ZnO NPs induces oxidative stress and transient injury in the rat lung 1) , as well as an increase in neutrophil cells in BALF 26) . Exposure of human cells to ZnO NPs also induces pro-inflammatory responses, such as increases in pro-inflammatory cytokines and chemokines 17−20) , among which IL-6 and CINCs are known to induce the accumulation of macrophages. These, along with other phagocytic cells, such as neutrophils, generate ROS 27, 28) . Thus, ZnO NPs cause two types of oxidative stress in the lung: primary (direct) stress caused by the released Zn 2+ , and secondary (indirect) stress caused by infiltration of neutrophils and macrophages.
In this study, we showed that AA, a well-known radical-scavenging antioxidant, inhibits the induction of pulmonary oxidative stress, injury, and inflammation observed in the rat lung 1 day after intratracheal instillation of ZnO NPs. HO-1 gene and protein expression increased in response to ZnO NP exposure, but not in rats given AA. These results suggest that AA suppresses oxidative stress caused by ZnO NPs. Analyses of BALF showed that AA also suppressed increases in IL-6 concentration and expression of the CINC gene family caused by ZnO NPs, as was increased LDH activity. These results suggest that AA suppresses both the induction of inflammation and injury. In contrast, MT-1 gene expression was induced following ZnO NP instillation, and remained elevated independently of AA, as our previous study with ZnO NPs and ZnCl 2 had indicated 1) . These results suggest that the Zn 2+ released from ZnO NPs induces MT-1 gene expression. We therefore conclude that AA has a suppressive effect on responses to oxidative stress, inflammation, and injury, but no effect on Zn 2+ released from ZnO NPs in the lung. The relationship between inhibition of oxidative stress and inhibition of inflammation by AA is unclear. There is a possibility, however, that the preventive effect of AA against inflammation is due to inhibition of the production of ROS caused by activation of phagocytes, such as neutrophils and macrophages. Our data show that AA suppressed expression of CINC genes. CINCs are known as neutrophil chemoattractants; therefore, inhibition of their expression is associated with inhibition of neutrophil activation and the resultant ROS genera- tion. AA possibly suppresses inflammation by an indirect mechanism: enhancement of the anti-oxidative system. Oxidative stress is strongly related to inflammation, and it is known that ROS have a role as inflammation mediators 29) . Generally, orally ingested AA is absorbed in the small intestine and transported to tissues in blood. In this study, we observed a significant increase in AA concentrations in blood samples from the AA groups. On the other hand, it is known that the intracellular Zn 2+ concentration is increased after ZnO NPs exposure 1) . Therefore, it is considered that induction of oxidative stress and inflammation caused by ZnO NPs in the lung was the result of uptake of ZnO NPs into cells. AA is also incorporated into cells through the membrane transporter SVCT 30) . In particular, it has been reported that both SVCT1 and SVCT2 are present in the human lung 31) . Consequently, there is the possibility that the AA was incorporated into the cells, and then showed the protective effect against the cytotoxicity of ZnO NPs in the cells. Moreover, there are also reports indicating that AA reduces intracellular lipid peroxidation induced by talc nanoparticles, and there are other reports indicating that AA inhibits intracellular ROS generation induced by silica nanoparticles 22, 23) . We therefore suggest that the supplied AA was transported to via the blood to lung tissue where it scavenged ROS caused by ZnO NPs. In this way, induction of pro-inflammatory responses mediated by ROS might be suppressed by AA acting as a radical scavenger. Nonetheless, the mechanism that induces ROS generation by ZnO NPs is unclear. There are two possibilities for the ROS generation mechanism. Namely, it is thought that the direct mechanism is Fenton-like reaction. In addition, there is also possibility that indirect mechanism is induced by dysfunction of mitochondrial electron transport system by Zn 2+ released from incorporated ZnO NPs. The clarifications of the ROS generation mechanism caused by ZnO NPs, and prevention mechanism by AA is the future investigation task. Moreover, we evaluated only single dose of both ZnO NPs and AA in this study, and so it is also necessary to evaluate multiple doses in a future investigation.
In conclusion, the present study shows that supply of AA with drinking water for 1 day after intratracheal instillation of ZnO NPs has a suppressive effect on acute pulmonary oxidative stress, inflammation, and injury caused by ZnO NPs, although the mechanism is still unclear.
